Eris Lifesciences has announced the appointment of Akhil Awasthi as a Non-Executive Director, bringing over 30 years of investment experience to the board. His expertise in private equity and ...
Roche's experimental drug, enicepatide, delivers significant weight loss and improved blood sugar control in type-2 diabetes patients according to Phase 2 trial results. With a 15.5% weight loss and ...
Novo Nordisk's CEO envisions a future where weight-loss pills capture 50% of the global obesity drug market by 2030, shifting ...
Novo Nordisk, the maker of Ozempic, aims to enter the hair-loss market as part of its strategy to diversify and leverage its ...
Cohance Lifesciences' API manufacturing site in Andhra Pradesh has received a Form 483 with five observations from the FDA, ...
European pharmaceutical companies urge governments to enhance spending and streamline drug trials to compete with the US and ...
Amgen's late-stage trial results for dazodalibep, an experimental drug for Sjogren's disease, indicate significant reduction in disease activity, leading to a 4% surge in shares. Discover the ...
The sale comes amid rising competition from brands such as Ayvakit, marketed by French major Sanofi. However, direct generic competition is expected to arrive only after 2029 in Europe and 2030 in the ...
Of the total 220 NSQ samples identified in August, includes several common medicines such as paracetamol, metformin combos (for diabetes), amoxicillin formulations (antibiotics), vitamin supplements ...
Approximately 96% completion, every certificate accounted for, with nothing overdue – this is what a quality head at an Indian formulation plant can pull up from her training dashboard in less than a ...
India's DCGI warns against the indiscriminate use of painkillers and antibiotics due to risks of chronic kidney disease, urging healthcare professionals to adhere to strict guidelines for medication.
Novo Nordisk's CagriSema shows significant weight loss benefits in diabetes patients, surpassing Eli Lilly's tirzepatide in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results